R&D

New Biotech Alliance in Saxony to Secure Growth and Jobs

"Today marks the start of a new era for Saxony as a stronghold of biotechnology," declared Roland Göhde, the President of registered association biosaxony e.V. and CEO of Partec GmbH from Görlitz, speaking on the successful merger of the two organizations biodresden e.V. and biosaxony e.V. Players in the biotech and life sciences sector throughout Saxony (Germany) will now be uniting their activities within the new joint association. After the members of biodresden e.V. had unanimously backed the merger on June 4, the decision was finally approved by the membership of biosaxony e.V. on June 10 in Leipzig.

Elsevier acquires Collexis

Elsevier, the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc., a leading developer of semantic technology and knowledge discovery software.

New tool to detect early-stage Alzheimer's disease

Researchers in Germany and the US have discovered that a new molecular imaging agent could be used to diagnose Alzheimer's disease (AD) during its early stages. Presented at the 57th annual meeting of the Society for Nuclear Medicine in Salt Lake City, US, the results of the clinical trial represent a possible breakthrough for the early detection of AD, an incurable degenerative disease that currently affects an estimated 26 million people worldwide.

British Medical Journal: WHO must act now to restore its credibility, and Europe should legislate

Council of Europe condemns "unjustified scare" over swine flu
Adrian O'Dowd
The Council of Europe has heavily criticised the World Health Organization, national governments, and EU agencies for their handling of the swine flu pandemic. The parliamentary assembly of the council - the international organisation that protects human rights and the rule of law in Europe - published a draft of a report that reviewed how the H1N1 pandemic was handled. National governments, WHO, and EU agencies had all been guilty of actions that led to a "waste of large sums of public money, and unjustified scares and fears about the health risks faced by the European public," says the report.

Progress in Exploring New Avenues for Brain Repair

The research team led by Professor Magdalena Götz of Helmholtz Zentrum München and Ludwig-Maximilians-Universität (LMU) Munich reports a major step forward in discovering a therapy for neurodegenerative diseases such as Alzheimer's or stroke. The researchers were able to convert glial cells of the brain into two different functional classes of neurons. The findings are published on May 18th in the renowned journal PLoS Biology.

Transinsight and antibodies-online Develop Software for Semantic Gene and Protein Identification

Since July 2009 Transinsight GmbH and antibodies-online GmbH partner together with TU Dresden and RESprotect GmbH to develop and deploy new semantic search technologies for the Life-Science industry. Their joint efforts are funded by the THESEUS research program from the German Federal Ministry of Economics and Technology (BMWi).

First DataBank Champions Patient Safety

Patient safety is a mission critical business goal for First DataBank, the UK's leading provider of drug databases and active clinical decision support. To highlight its vision of a world free of medication errors, First DataBank is again sponsoring the 'best use of IT to promote patient safety' category of the E-Health Insider Awards in association with BT.

Research & Development

New Biotech Alliance in Saxony to Secure Growth and Jobs

Elsevier acquires Collexis

New tool to detect early-stage Alzheimer's disease

British Medical Journal: WHO must act now to restore its credibility, and Europe should legislate

Progress in Exploring New Avenues for Brain Repair

Transinsight and antibodies-online Develop Software for Semantic Gene and Protein Identification

First DataBank Champions Patient Safety

More Pharma News ...